@article{SchoenbornWeitmannGreinacheretal.2020,
  author    = {Linda Sch{\"o}nborn and Kerstin Weitmann and Andreas Greinacher and Wolfgang Hoffmann},
  title     = {Characteristics of Recipients of Red Blood Cell Concentrates in a German Federal State},
  series   = {Transfusion Medicine and Hemotherapy},
  volume    = {47},
  number    = {5},
  publisher = {S. Karger AG},
  address   = {Basel, Switzerland},
  issn      = {1660-3796},
  doi       = {10.1159/000510207},
  url       = {https://nbn-resolving.org/urn:nbn:de:gbv:9-opus-56841},
  pages     = {370 -- 378},
  year      = {2020},
  abstract  = {Background: Annual transfusion rates in many European countries range between 25 and 35 red blood cell concentrates (RBCs)/1,000 population.It is unclear why transfusion rates in Germany are considerably higher (approx. 50–55 RBCs/1,000 population). Methods: We assessed the characteristics of transfusion recipients at all hospitals of the German federal state Mecklenburg-Western Pomerania during a 10-year longitudinal study. Results: Although 75\% of patients received ≤4 RBCs/patient in 2015 (1 RBC: 11.3\%; 2 RBCs: 42.6\%; 3 RBCs: 6.3\%; 4 RBCs: 15.0\%), the mean transfusion index was 4.6 RBCs due to a minority of patients with a high transfusion demand. Two thirds of all RBCs were transfused to only 25\% of RBC recipients. Consistently, male patients received a higher number of RBCs (2005: 54.2\%; 2015: 56.8\%) and had a higher mean transfusion index than female patients (mean 5.1 ± 7.2; median 2; inter-quartile range [IQR] 2–4 vs. mean 4.0 ± 5.8; median 2; IQR 2–4). The absolute transfusion demand decreased between 2005 and 2015 by 13.5\% due to a composite of active reduction (clinical practice change) and population decline in the 65- to 75-year age group (lower birth rate cohort 1940–1950); however, with major differences between hospitals (range from –61.0 to +41.4\%). Conclusion: Transfusion demand in a population could largely be driven by patients with high transfusion demand. Different treatment practices in this group of patients probably add to the major differences in transfusion demand per 1,000 individuals between countries. The available data cannot prove this hypothesis. Implementation of a diagnosis-related group-based monitoring system is urgently needed to allow informative monitoring on the population level and meaningful comparisons between transfusion practices.},
  language  = {en}
}